Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy

Creative Commons License

Topkan E., Parlak C., Kotek A., Yapar A. F., Pehlivan B.

BMC GASTROENTEROLOGY, cilt.11, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 11
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1186/1471-230x-11-123
  • Dergi Adı: BMC GASTROENTEROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Anahtar Kelimeler: Concurrent chemoradiotherapy, locally advanced pancreas cancer, positron emission tomography, metabolic response, clinical outcome prediction, POSITRON-EMISSION-TOMOGRAPHY, F-18 FLUORODEOXYGLUCOSE, FDG-PET, STEREOTACTIC RADIOSURGERY, DIFFERENTIAL-DIAGNOSIS, COMPUTED-TOMOGRAPHY, RADIATION-THERAPY, LUNG-CANCER, GEMCITABINE, CT
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: We aimed to study the predictive value of combined 18F-fluoro-deoxy-D-glucose positron emission tomography and computerized tomography (FDG-PET-CT), on outcomes in locally advanced pancreatic carcinoma (LAPC) patients treated with concurrent chemoradiotherapy (C-CRT).